CORC

浏览/检索结果: 共3条,第1-3条 帮助

限定条件                
已选(0)清除 条数/页:   排序方式:
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载:48/0  |  提交时间:2019/12/05
Efficacy and Safety of All-Oral, 12-Week Ravidasvir Plus Ritonavir-Boosted Danoprevir and Ribavirin in Treatment-Naive Non-Cirrhotic HCV Genotype 1 Patients : Results from a Phase 2/ 3 Clinical Trial in China 会议论文
作者:  Wei, Lai;  Xu, Xiaoyun;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Jifang
收藏  |  浏览/下载:14/0  |  提交时间:2019/12/05
Screening of Key Genes Associated with Ischemic Stroke via Microarray Data 期刊论文
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2013, 卷号: 40, 期号: 6
作者:  Wang, Jianmin;  Zhou, Dongliang;  Qin, Hongwei;  Xu, Ying;  Guan, Ying
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/19


©版权所有 ©2017 CSpace - Powered by CSpace